A detailed history of Steven Cohen (Point72 Asset Management, L.P.) transactions in Caribou Biosciences, Inc. stock. As of the latest transaction made, Point72 Asset Management, L.P. holds 2,343,540 shares of CRBU stock, worth $6.44 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
2,343,540
Previous 2,343,540 -0.0%
Holding current value
$6.44 Million
Previous $3.84 Million -0.0%
% of portfolio
0.01%
Previous 0.01%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$1.62 - $5.05 $2.01 Million - $6.27 Million
-1,241,478 Reduced 34.63%
2,343,540 $3.84 Million
Q1 2024

May 15, 2024

BUY
$4.82 - $8.26 $306,754 - $525,682
63,642 Added 1.81%
3,585,018 $18.4 Million
Q4 2023

Feb 14, 2024

BUY
$3.58 - $6.25 $77,123 - $134,643
21,543 Added 0.62%
3,521,376 $20.2 Million
Q3 2023

Nov 14, 2023

BUY
$4.08 - $8.14 $13.1 Million - $26.1 Million
3,210,094 Added 1107.93%
3,499,833 $16.7 Million
Q4 2022

Feb 14, 2023

BUY
$5.57 - $11.01 $1.61 Million - $3.19 Million
289,739 New
289,739 $1.82 Million
Q3 2021

Nov 15, 2021

BUY
$15.75 - $30.29 $4.56 Million - $8.78 Million
289,739 New
289,739 $6.92 Million

Others Institutions Holding CRBU

About Caribou Biosciences, Inc.


  • Ticker CRBU
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 60,840,800
  • Market Cap $167M
  • Description
  • Caribou Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the development of genome-edited allogeneic cell therapies for the treatment of hematologic malignancies and solid tumors in the United States and internationally. Its lead product candidates are CB-010, an allogeneic anti-CD19 CAR-T cell therapy that is in phase 1...
More about CRBU
Track Steven Cohen's Portfolio

Track Steven Cohen Portfolio

Follow Steven Cohen (Point72 Asset Management, L.P.) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.